Onset and duration of action of levocabastine nasal spray in atopic patients under nasal challenge conditions.

Corren, J; Rachelefsky, G; Spector, S; Schanker, H; Siegel, S; Holton, D; Karcher, K; Travers, S

Corren, J; Rachelefsky, G; Spector, S; Schanker, H; Siegel, S; Holton, D; Karcher, K; Travers, S.

Affiliation

Corren J; Allergy Research Foundation, Inc, Los Angeles, CA 90025, USA.

J Allergy Clin Immunol ; 103(4): 574-80, 1999 Apr.

Article in En | MEDLINE | ID: mdl-10200003

Subject(s)

Histamine H1 Antagonists/therapeutic use; Nasal Provocation Tests; Piperidines/therapeutic use; Rhinitis, Allergic, Seasonal/drug therapy; Administration, Intranasal; Adult; Allergens/administration & dosage; Allergens/immunology; Cross-Over Studies; Dose-Response Relationship, Drug; Female; Histamine H1 Antagonists/administration & dosage; Histamine H1 Antagonists/pharmacokinetics; Humans; Male; Middle Aged; Piperidines/administration & dosage; Piperidines/pharmacokinetics; Poaceae/adverse effects; Pollen/adverse effects; Pollen/immunology; Rhinitis, Allergic, Seasonal/metabolism; Severity of Illness Index; Single-Blind Method; Trees/adverse effects

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Piperidines / Rhinitis, Allergic, Seasonal / Histamine H1 Antagonists / Nasal Provocation Tests Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Allergy Clin Immunol Year: 1999 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links